MAPT and tauopathy: In 2018, Zhang and colleagues tested CNDR-51657, a prototype of TPD, on a PS19 transgenic mouse model of tauopathies which expresses the P301S mutant form of human tau and shows the progressive accumulation of neurofibrillary tangles with age [294].